跳至主要内容
临床试验/NCT03078140
NCT03078140已完成不适用

The Study to Compare Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation

Chiang Mai University1 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
208
试验地点
1
主要终点
iodine status

研究概览

简要总结

Pregnant women who attend at our antenatal clinic will random to 2 groups. First will receive routine iodine supplementation. The other will receive iodinated pill or only iron supplementation base on their urine iodine status.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • first visit for antenatal care in the first trimester
  • singleton pregnancy
  • delivered at Maharaj Nakorn Chiangmai Hospital

排除标准

  • thyroid disease which diagnosed before pregnancy or currently
  • history of thyroid gland surgery or iodine ablation therapy
  • received iodine supplement before pregnancy
  • received any medication for thyroid disease treatment, within 6 weeks postpartum women or breast feeding period
  • family history of thyroid disease
  • having underlying disease or contraindication which cannot received iodine supplement
  • loss follow-up or incomplete data.

研究组 & 干预措施

Triferdine

Active Comparator

Triferdine 1 tablet by mouth daily. Start after 1st trimester until delivery

干预措施: Triferdine (Dietary Supplement)

Triferdine/Ferli-6

Active Comparator

Triferdine or ferli-6 1 tablet by mouth daily base on iodine status. The supplement will give after 1st trimester until delivery

干预措施: Triferdine/Ferli-6 (Dietary Supplement)

结局指标

主要结局

iodine status

时间窗: at delivery

mean urine iodine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kuntharee Traisrisilp

Principle Investigator

Chiang Mai University

研究点 (1)

Loading locations...

相似试验